4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-15-045407
Chief Technology Officer acquired 120,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WACHTER ERIC PHD Chief Technology Officer | 2015-12-21 | Option exercise | +120,000 | $1.02 | $122,400 | 5,513,236 | D |
| Derivatives | |||||||
| WACHTER ERIC PHD Chief Technology Officer | 2015-12-21 | Option exercise · Employee Stock Option (right to buy) | −120,000 | 120,000 | D | ||
Loading xslF345X03/doc1.xml…